The Klaipėda University Hospital is seeking suppliers for disposable tools specifically designed for molecular testing. This contract involves providing equipment that will be used in laboratory settings for various molecular analysis procedures. Suppliers should ensure that the products meet the ne
Tender closed on 30 Dec 2025. Awaiting award.
This contract opportunity is for the procurement of a 3 Tesla magnetic resonance imaging (MRI) system to be purchased on an installment plan over 37 months. The system is intended for use in the health sector, specifically by the Klaipėda University Hospital. Suppliers interested in this opportunity
This contract is for the supply of various medical devices and products, specifically focusing on single-use sterile surgical kits. The supplier will also be required to implement an automated inventory management system for these products based on usage. The primary goal is to ensure the availabili
This contract opportunity is for the supply of blood components specifically intended for patients with oncohematological conditions. The buyer, VšĮ Klaipėdos universiteto ligoninė, is seeking suppliers who can provide these essential medical products. The deadline for submissions is January 19, 202
This contract opportunity is for laboratory services, specifically laboratory testing. The buyer, VšĮ Klaipėdos universiteto ligoninė, is seeking suppliers to provide these services. The total value of the contract is €300,000. The awarded supplier is VšĮ Vilniaus universiteto ligoninė Santaros klin
Funding up to £3 million for human experimental medicine studies investigating the biological and psychological causes of gambling disorder development and recovery.
Apply for up to £26.25 million in MRC funding over 14 years to establish a centre of research excellence addressing complex health challenges.
Grants up to £200,000 available for early-stage, high-risk environmental research projects without requiring preliminary data, running for up to two years.
UKRI is funding empirical research to establish reliable estimates of the economic and social returns on R&D investments to guide public and private sector decision-making.
